Validation of robust tools to measure sialorrhea in amyotrophic lateral sclerosis: A study in a large French cohort

Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

Volumn 14, Issue 4, 2013, Pages 302-307

  Abdelnour Mallet, Maya ^a   Tezenas Du Montcel, Sophie ^a,b   Cazzolli, Pamela A ^c   Assouline, Avi ^d   Pointon, Christine ^a   Leveque, Nathalie ^a,e   Dominique, Henri ^a   Elmazria, Hassan ^a   Rothmayer, Michaela ^a   Lenglet, Timothee ^a   Bruneteau, Gaelle ^a   Le Forestier, Nadine ^a   Delanian, Sylvie ^f   Gonzalez Bermejo, Jesus ^a   Salachas, François ^a   Brooks, Benjamin Rix ^g   Pradat, Pierre François ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c ALS Care Project   (United States)

^d Centre Clinique de la Porte de Saint Cloud   (France)

^e UNIVERSITÉ SORBONNE NOUVELLE PARIS 3   (France)

^f SAINT LOUIS HOSPITAL   (France)

^g UNIVERSITY OF NORTH CAROLINA AT CHARLOTTE   (United States)

Author keywords

Risk; Therapy; Ventilation

Indexed keywords

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CAREGIVER; CLINICAL ASSESSMENT; CLINICAL ASSESSMENT TOOL; CLINICAL EVALUATION; COHORT ANALYSIS; CONTROLLED STUDY; HUMAN; HYPERSALIVATION; INTERRATER RELIABILITY; INTRARATER RELIABILITY; MAJOR CLINICAL STUDY; NEUROLOGIST; NURSE; ORAL SECRETION SCALE; PARKINSON DISEASE; PRIORITY JOURNAL; SCORING SYSTEM; SIALORRHEA SCORING SCALE; SPEECH THERAPY; VALIDATION PROCESS;

ADULT; AGED; AGED, 80 AND OVER; AMYOTROPHIC LATERAL SCLEROSIS; COHORT STUDIES; FEMALE; FRANCE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; SIALORRHEA;

EID: 84877850893     PISSN: 21678421     EISSN: 21679223     Source Type: Journal    
DOI: 10.3109/21678421.2012.735238     Document Type: Article

References (8)

1. Corcia P, Pradat P F, S alachas F, B runeteau G, F orestier N, Seilhean D.et al. Causes of death in a post mortem series of ALS patients. Amyotroph Lateral Scler. 2008; 9 : 59-62 (Pubitemid 351260374)
2. Andersen P M, A brahams S, B orasio G D, d e Carvalho M, Chio A, van Damme P.et al. EFNS guidelines on the Clinical Management of Amyotrophic Lateral Sclerosis (MALS):Revised report of an EFNS task force. Eur J Neurol. 2012; 19 : 360-75
3. Cedarbaum JM, S tambler N, M alta E, F uller C, H ilt D, Thurmond B.et al. The ALSFRS-R: A revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). J Neurol Sci. 1999; 169 : 13-21 (Pubitemid 29502501)
4. Cazzolli PA, B rooks BR, L ewarski JL, M cKim DA, C hatburn RL. Oral Secretion Scale (OSS) Score in amyotrophic lateral sclerosis patients is associated with tolerance of non-invasive positive pressure ventilation, need for hospice or transition to tracheal positive pressure ventilation (TPPV) and survival (abstract from a poster presentation at the 21st Symposium on ALS/MND, Orlando, USA, 2010). Amyotroph Lateral Scler. 2010; 11(Suppl 1) : 140
5. Arbouw ME, M ovig KL, K oopmann M, P oels PJ, G uchelaar HJ, Egberts T.C.et al. Glycopyrrolate for sialorrhea in Parkinson ' s disease: A randomized, double-blind, crossover trial. Neurology. 2010; 74 : 1203-7
6. Mier RJ, B achrach SJ, L akin RC, B arker T, C hilds J, M oran M. Treatment of sialorrhea with glycopyrrolate: A doubleblind, dose-ranging study. Arch Pediatr Adolesc Med. 2000; 154 : 1214-8
7. Nakayama Y, O gura A, M atsuda C, S himizu T, C azzolli P, Brooks BR. Oral Secretion Scale-Test-re-test Reliablity Pilot Study in a Japanese Amyotrophic Lateral Sclerosis Population (abstract from a poster presentation at the 21 st Symposium on ALS/MND, Orlando, USA, 2010). Amyotroph Lateral Scler. 2010; 11(Suppl 1) : 141
8. Maclure M, W illett W C. M isinterpretation and misuse of the kappa statistic. Am J Epidemiol. 1987; 126 : 161-9